Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICOS-ONE - Prevention of Anthracycline-induced Cardiotoxicity
NCT01968200Phase 3Unknown
- Sponsor
- European Institute of Oncology
- Start
- Dec 2012
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of enalapril in anthracycline-induced cardiotoxicity, sponsored by European Institute of Oncology. Status: unknown.
02
Drugs
enalapril
03
Conditions
anthracycline-induced cardiotoxicity
Beyond the preview
Go deeper on NCT01968200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01968200.